Navigation Links
Synthes and Lilly Sign Development and Collaboration Agreement
Date:6/9/2011

fore you try to inject FORTEO yourself, a healthcare provider should teach you how to use the FORTEO Delivery Device to give your injection the right way. Inject FORTEO one time each day in your thigh or abdomen (lower stomach area). Do not inject all the medicine in the FORTEO Delivery Device at any one time. Do not transfer the medicine from the FORTEO Delivery Device to a syringe. This can result in taking the wrong dose of FORTEO. If you take more FORTEO than prescribed, call your healthcare provider. If you take too much FORTEO, you may have nausea, vomiting, weakness, or dizziness.

How should I store FORTEO?

  • Keep your FORTEO Delivery Device in the refrigerator between 36 degrees F to 46 degrees F (2 degrees C to 8 degrees C). Do not freeze the FORTEO Delivery Device. Do not use FORTEO if it has been frozen. Do not use FORTEO after the expiration date printed on the delivery device and packaging. Throw away the FORTEO Delivery Device after 28 days even if it has medicine in it (see the User Manual).

For more safety information, please see Medication Guide (http://pi.lilly.com/us/forteo-medguide.pdf) and Prescribing Information, including Boxed Warning (http://pi.lilly.com/us/forteo-pi.pdf).  Please see full user manual that accompanies the delivery device.

TE Con ISI  07Mar2011

This press release contains certain forward-looking statements about the collaboration between Synthes and Lilly and about Forteo for the treatment of osteoporosis in patients who are at high risk for a fracture. It reflects Synthes’ and Lilly’s current beliefs. As with any pharmaceutical product, there are substantial risks and uncertainties in the process of development and commercialization. There is no guarantee that future study results and patient experi
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. BGI Releases a Complete De Novo E. Coli O104 Genome Assembly and is Making Its Detection Kit Protocols and Synthesized Primers Freely Available to Worldwide Disease Control and Research Agencies
2. Johnson & Johnson and Synthes Announce Definitive Merger Agreement to Create Worlds Most Innovative and Comprehensive Orthopaedics Business
3. Hologics Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel
4. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Wins 2009 Silver Innovation Award
5. U.S. District Court Rules in Favor of Lilly in Amylin Litigation
6. FDA Approves Updates to Lillys Humalog® (insulin lispro injection [rDNA origin]) Label
7. Correction: Lilly Presents Data on Cixutumumab in Five Subtypes of Sarcomas
8. Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly
9. Lilly Comments on Court Ruling in Amylin Litigation
10. Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement
11. Study Determined Best Dose and Showed 55 Percent Response Rate With Lilly Anti-BAFF Monoclonal Antibody in Previously-Treated Multiple Myeloma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... WELWYN GARDEN CITY, England and ... Heptares Therapeutics, the leading GPCR drug discovery and development company, ... Akira Usui as a Consultant to augment the Company,s ... Asian territories. Mr Usui has more than 15 years ... pharmaceutical industry including senior roles at Perlegen Sciences, Inc., Roche Pharma ...
(Date:5/23/2013)... , May 23, 2013 Amgen (NASDAQ: ... th Annual  Healthcare Conference on Thursday, May 30, 2013, ... , beginning at 9:20 a.m. Eastern Daylight Time. ... Amgen, will present at the conference. Live audio of the ... website, www.amgen.com , under Investors. A replay of the ...
(Date:5/23/2013)... 23, 2013  A recently published clinical study conducted ... Texas , demonstrates that 3D mammography (breast tomosynthesis) ... The study, "Implementation of Breast Tomosynthesis ... led by Stephen L. Rose , ... American Journal of Roentgenology (AJR). The AJR ...
Breaking Medicine Technology:Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3
... ARBOR, Mich., April 7, 2011 Adeona Pharmaceuticals, Inc. (AMEX: ... serious central nervous system diseases, announced today that it has ... its common stock at approximately $2.0725 per share to a ... million in gross proceeds. The investor will also receive warrants ...
... April 7, 2011 Inhibitex, Inc. (Nasdaq: INHX ... of 11,463,415 shares of its common stock, at a purchase ... of $47 million. The net proceeds to Inhibitex from the sale ... offering expenses, are expected to be approximately $44 million.  Inhibitex ...
Cached Medicine Technology:Adeona to Raise $3.5 Million in Registered Direct Offering 2Adeona to Raise $3.5 Million in Registered Direct Offering 3Inhibitex Prices $47 Million Public Offering 2Inhibitex Prices $47 Million Public Offering 3
(Date:5/25/2013)... Acuity Games ’ innovative brain games have ... Word Hunt is available today, expanding it beyond its ... 2, Sudoku and Matchematics will roll out over the next ... lifetime brain fitness measurement have been re-optimized for the iPhone's ... brain fitness measurement in your pocket. What could be ...
(Date:5/25/2013)... 2013 IBISWorld estimates that revenue for the ... annual rate of 28.7% to $1.0 billion in the five ... 2002 and 2008, no new cell therapy products were introduced, ... growth during that period. In the years since, however, the ... This factor contributed to the industry's fast growth during the ...
(Date:5/25/2013)... Houston, Texas (PRWEB) May 25, 2013 ... more stressful than finals week. Increasingly, they are ... them stay awake and study. For more on ... Associates, a drug treatment facility, warns that students ... through finals” are at risk for developing a ...
(Date:5/25/2013)... Ayurveda is the traditional medicine of India. Translated ... While a medical science, its scope enters into the realms ... philosophy is that disease is the end result of living ... order to re-establish optimal health, we must discover where we ... style which brings us back into harmony. , The California ...
(Date:5/25/2013)... The current residents of Back2Basics - Long Term ... staff all came together Saturday, May 18th to celebrate the ... Cuisine, the residents got up to thank Roy Duprez, CEO ... road to recovery, and giving them a second chance at ... 2010 after realizing the need for a long-term facility. ...
Breaking Medicine News(10 mins):Health News:Acuity Games Apps Come to the iPhone 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2Health News:Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes 2Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2
... Conn., March 30 Anthem Blue Cross and Blue ... a Brand Excellence Award from the Blue Cross and ... Blue Cross and Blue Shield companies that excel in ... Shield Brand image."The Blue Cross and Blue Shield Brands ...
... an important building block of social interaction that prompts ... these children pay attention to physical relationships between movement ... the Yale School of Medicine report their results in ... , "Human infants are born in a fragile ...
... March 30 Golub Capital today announced that it ... equity to support the acquisition of Network Express, Inc., ... Street Capital. The combination of Ace Expediters, Inc., (which ... Network Express, Inc., creates the leading dedicated route logistics ...
... newborn is small, doctors should be aware, study says , , ... their due date have an increased risk of developmental delays ... thought to have little to no risk of long-term problems, ... "late pre-term") have as much as a 36 percent higher ...
... with Uncertain Origins Demonstrates Unmatched PerformanceREDWOOD CITY, Calif., March ... focused on oncology, announced today that the Journal ... the results of the Pathwork(R) Tissue of Origin Test ... a 1,550-Gene Expression Profile for Identification of Tumor Tissue ...
... PharmAthene, Inc. (NYSE Amex: PIP ), a ... threats, today reported operational and financial results for the ... December 31, 2008 and 2007, the Company reported revenues ... for the full year 2008 consisted primarily of contract ...
Cached Medicine News:Health News:Anthem Blue Cross and Blue Shield in Connecticut Receives Prestigious Brand Excellence Award 2Health News:Yale researchers discover mechanism for 2Health News:Golub Capital Provides Debt Financing to Support the Acquisition of Network Express, Inc., by Ace Expediters, Inc. 2Health News:Babies Born Only 2 to 3 Weeks Early May Face Development Delays 2Health News:Babies Born Only 2 to 3 Weeks Early May Face Development Delays 3Health News:Pathwork Tissue of Origin Test Validation Study Published in Journal of Clinical Oncology 2Health News:Pathwork Tissue of Origin Test Validation Study Published in Journal of Clinical Oncology 3Health News:PharmAthene Reports Year End 2008 Financial Results 2Health News:PharmAthene Reports Year End 2008 Financial Results 3Health News:PharmAthene Reports Year End 2008 Financial Results 4Health News:PharmAthene Reports Year End 2008 Financial Results 5Health News:PharmAthene Reports Year End 2008 Financial Results 6Health News:PharmAthene Reports Year End 2008 Financial Results 7
Long handle occluders are approximately 9 inches long....
Manual Lensmeter....
Lightweight, cordless lensmeter....
... 101 is well suited for measuring ... well as conventional spectacle lenses. It ... a full 90-degree inclination, which facilitates ... used in the vertical position. The ...
Medicine Products: